Researchers have looked at a sample population of senior adults newly diagnosed with wet age-related macular degeneration (exudative, or neovascular, AMD) and found that those who received either Lucentis or Avastin injections* were 19% less likely to be admitted to a long-term care facility during the follow-up period. The reason? The introduction of anti-VEGF therapy [Read More]
Category: Latest News
U-M Kellogg Eye Center performs first two retinal prosthesis implants in U.S. since FDA approval
Kellogg retina surgeons implant Argus II Retinal Prosthesis, or ‘bionic eye,’ for two patients with end-stage retinitis pigmentosa ANN ARBOR, Mich. — Retina surgeons at the University of Michigan Kellogg Eye Center have performed the first – and second – surgeries in the United States to implant an artificial retina, or “bionic eye,” since the U.S. Food and [Read More]
Findings Help Predict AMD Advancement
A 10-year follow-up study of participants in the original AREDS trial has been completed. The Age-Related Eye Disease Study Research Group revealed new statistics on the risk and rate of progression from early to advanced age-related macular degeneration (AMD). Participants aged 55 to 80 years with no AMD or AMD of varying severity were followed [Read More]
Choroideremia Gene Therapy Showing Promise
Researchers at Oxford University have reported successful findings from their Phase 1/2 clinical testing of the CHM gene for treatment of choroideremia. Choroideremia is a rare disease affecting mostly males that leads to blindness. In the multicentre clinical trial, six male patients (aged 35—63 years) all showed improvement after replacement of the malfunctioning gene. The [Read More]
There’s so much more in life to see
January is National Glaucoma Month The best years are yet to come. With more free time, you can set your sights on wonderful places to go and people to see. Just make sure you keep an eye on glaucoma. Glaucoma is a group of diseases that damages the eye’s optic nerve, which carries visual signals [Read More]